The Response of Drug Expenditure to Nonlinear Contract Design: Evidence From Medicare Part D *

Quarterly Journal of Economics - United Kingdom
doi 10.1093/qje/qjv005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

The Response of Drug Expenditures to Non-Linear Contract Design: Evidence From Medicare Part D

2013English

Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D

2015English

Salience, Myopia, and Complex Dynamic Incentives: Evidence From Medicare Part D

2015English

Radiation Oncology Drug Prescription Patterns in Medicare Part D

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Changes to Medicare Part D: Who Benefits?

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2010English

Choice Inconsistencies Among the Elderly: Evidence From Plan Choice in the Medicare Part D Program

2009English

Government Payments and Insurer Benefit Design in Medicare Part D

SSRN Electronic Journal
2014English

Insurers’ Response to Selection Risk: Evidence From Medicare Enrollment Reforms

Journal of Health Economics
Health PolicyPublic HealthOccupational HealthEnvironmental
2017English

Should Drug Prices Be Negotiated Under Part D of Medicare? And if So, How?

Health Affairs
MedicineHealth Policy
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy